The government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions Thursday to lower an uncommon but potentially life-threatening risk that ...
Government health advisers Thursday called for restrictions on some long-acting asthma drugs, but spared Advair, a top-selling medication used by millions of patients. Government health advisers ...
WASHINGTON — Two federal drug officials have concluded that asthma patients risk death if they continue to use four hugely popular asthma drugs: Advair, Symbicort, Serevent and Foradil. But the ...
The government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions Thursday to lower an uncommon but potentially life-threatening risk that ...
— The government is taking steps to curb use of some long-acting asthma drugs used by millions. It issued safety restrictions Thursday to lower a life-threatening risk that asthma could worsen ...
GlaxoSmithKline said today its asthma drug Advair fared better than AstraZeneca’s Symbicort in a one-year clinical study, stirring up rival claims about the two products. According to a recent ...
It's no secret that respiratory drugs make up a crowded field, and forthcoming generics will make the competition tougher still. AstraZeneca's Symbicort is no stranger to the fallout, either, what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results